Sökning: WFRF:(Saberi Hosnijeh Fatemeh)
> (2016) >
Soluble B-cell acti...
Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas : a nested case-control study and meta-analyses
-
Hosnijeh, Fatemeh Saberi (författare)
-
Portengen, Lutzen (författare)
-
- Späth, Florentin (författare)
- Umeå universitet,Onkologi
-
visa fler...
-
- Bergdahl, Ingvar A (författare)
- Umeå universitet,Enheten för biobanksforskning,Yrkes- och miljömedicin
-
- Melin, Beatrice (författare)
- Umeå universitet,Onkologi
-
Mattiello, Amalia (författare)
-
Masala, Giovanna (författare)
-
Sacerdote, Carlotta (författare)
-
Naccarati, Alessio (författare)
-
Krogh, Vittorio (författare)
-
Tumino, Rosario (författare)
-
Chadeau-Hyam, Marc (författare)
-
Vineis, Paolo (författare)
-
Vermeulen, Roel (författare)
-
visa färre...
-
(creator_code:org_t)
- 2016-01-08
- 2016
- Engelska.
-
Ingår i: International Journal of Cancer. - : John Wiley & Sons. - 0020-7136 .- 1097-0215. ; 138:10, s. 2357-2367
- Relaterad länk:
-
https://onlinelibrar...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Pre-diagnostic serum/plasma concentrations of B-cell activation markers have been associated with future risk of B-cell lymphomas (BCL) in HIV-infected patients and in the general population. Current evidence for the general population is however limited and relies on relatively small numbers of observations, especially for specific histologies. We carried out a nested case-control study, including 218 BCL and 218 matched controls, within two prospective cohorts, to investigate the association between plasma levels of soluble (s)CD27 and sCD30 and future risk of BCL, and main histologic subtypes separately. To expand the evidence further, we performed meta-analyses of the published data on these associations from prospective studies among the general population. Our study revealed a significant relationship between sCD30 concentration and BCL risk (OR=0.86, 1.53, 1.76, for the 2(nd) -4(th) quartiles respectively, P-trend=0.01). Similar increased risks were observed for diffuse large B-cell lymphoma and follicular lymphoma. Analyses of sCD27 blood concentrations did not show significant associations with BCL, (OR=0.90, 1.26, 1.65 for the 2(nd) -4(th) quartiles, respectively, P-trend=0.17), but significant associations were observed for chronic lymphocytic leukaemia and for the group of 'other BCL' subtypes. Our findings involving sCD30 were confirmed within our meta-analyses of five prospective cohorts, while results were more heterogeneous for sCD27 with the exception of CLL which was found consistently in all studies. Data to date suggest that chronic B-cell stimulation might be an important mechanism involved in B-cell lymphomagenesis both in HIV-infected and in the general population.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- lymphoma
- sCD30
- sCD27
- meta-analyses
- prospective study
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Hosnijeh, Fateme ...
-
Portengen, Lutze ...
-
Späth, Florentin
-
Bergdahl, Ingvar ...
-
Melin, Beatrice
-
Mattiello, Amali ...
-
visa fler...
-
Masala, Giovanna
-
Sacerdote, Carlo ...
-
Naccarati, Aless ...
-
Krogh, Vittorio
-
Tumino, Rosario
-
Chadeau-Hyam, Ma ...
-
Vineis, Paolo
-
Vermeulen, Roel
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
International Jo ...
- Av lärosätet
-
Umeå universitet